TY - JOUR
T1 - Understanding the dynamics of rapidly evolving pathogens through modeling the tempo of antigenic change
T2 - Influenza as a case study
AU - Koelle, Katia
AU - Kamradt, Meredith
AU - Pascual, Mercedes
N1 - Funding Information:
We thank J. Lloyd-Smith and S. Cobey for their helpful insights and feedback, and Brian Finkelman for his ‘phenodynamic’ insights. Support for K.K. and M.P. was provided by a Centennial fellowship of the James S. McDonnell Foundation to M.P.; further support for K.K. and support for M.K. was provided by grant NSF-EF-08-27416 and by the RAPIDD program of the Science and Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. MP is an investigator of the Howard Hughes Medical Institute.
PY - 2009/6
Y1 - 2009/6
N2 - Rapidly evolving pathogens present a major conceptual and mathematical challenge to our understanding of disease dynamics. For these pathogens, the simulation of disease dynamics requires the use of computational models that incorporate pathogen evolution. Currently, these models are limited by two factors. First, their computational complexity hinders their numerical analysis and the ease with which parameters can be statistically estimated. Second, their formulations are frequently not sufficiently general to allow for alternative immunological hypotheses to be considered. Here, we introduce a new modeling framework for rapidly evolving pathogens that lessens both of these limitations. At its core, the proposed framework differs from previous multi-strain models by modeling the tempo of antigenic change instead of the pathogen's genetic change. This shift in focus results in a new model of reduced computational complexity that can accommodate different immunological hypotheses. We demonstrate the utility of this antigenic tempo model in an application to influenza. We show that, under different parameterizations, the model can reproduce the qualitative findings of a diverse set of previously published flu models, despite being less computationally intensive. These advantages of the antigenic tempo model make it a useful alternative to address several outstanding questions for rapidly evolving pathogens.
AB - Rapidly evolving pathogens present a major conceptual and mathematical challenge to our understanding of disease dynamics. For these pathogens, the simulation of disease dynamics requires the use of computational models that incorporate pathogen evolution. Currently, these models are limited by two factors. First, their computational complexity hinders their numerical analysis and the ease with which parameters can be statistically estimated. Second, their formulations are frequently not sufficiently general to allow for alternative immunological hypotheses to be considered. Here, we introduce a new modeling framework for rapidly evolving pathogens that lessens both of these limitations. At its core, the proposed framework differs from previous multi-strain models by modeling the tempo of antigenic change instead of the pathogen's genetic change. This shift in focus results in a new model of reduced computational complexity that can accommodate different immunological hypotheses. We demonstrate the utility of this antigenic tempo model in an application to influenza. We show that, under different parameterizations, the model can reproduce the qualitative findings of a diverse set of previously published flu models, despite being less computationally intensive. These advantages of the antigenic tempo model make it a useful alternative to address several outstanding questions for rapidly evolving pathogens.
KW - Multi-strain model
KW - Rapid evolution
KW - RNA virus
UR - http://www.scopus.com/inward/record.url?scp=67649432813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67649432813&partnerID=8YFLogxK
U2 - 10.1016/j.epidem.2009.05.003
DO - 10.1016/j.epidem.2009.05.003
M3 - Article
C2 - 21352760
AN - SCOPUS:67649432813
SN - 1755-4365
VL - 1
SP - 129
EP - 137
JO - Epidemics
JF - Epidemics
IS - 2
ER -